Welcome aboard...Lucky newcomers...
For me the latest SP movement is an exchange of shares from peoples that want out to peoples that want in.
For the newcomers that did get in, here is a quote from the latest TLT-Presentation that resume very well what you did get for your money.
Date 10-23-2023.
https://theralase.com/wp-content/uploads/2023/10/Theralase-Corporate-Presentation-LIFE-Financing-10-23-2023.pdf Page 19, paragraph 4...
TLT said "
Interim data to date trending better than FDA approved Keytruda(Pembrolizumab) (61.7% improvement in CR and 90.5% improvement in duration of CR) an Adstiladrin (27.5% improvement in CR and 53.2% improvement in duration of CR)".
Although I don't like to compare Adstiladrin to Ruvidar because of it's very big immunodeficient restriction, nevertheless Adstiladrin did get the FDA BTD approval even with this big restriction.
With much better numbers TLT-Ruvidar has no restrictions whatsoever(that is huge).
Read the
highlighted paragraph a few time, and you will understand why you just made a very good investment.
Welcome aboard.